Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172
Open accessThe DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
The endogenous cannabinoid anandamide is removed from the synaptic space by a high-affinity transport system present in neurons and astrocytes, which is inhibited by N -(4-hydroxyphenyl)-arachidonamide (AM404). After internalization, anandamide is hydrolyzed by fatty-acid amide hydrolase (FAAH), an intracellular membrane-bound enzyme that also cleaves AM404. Based on kinetic evidence, it has recently been suggested that anandamide internalization may be mediated by passive diffusion driven by FAAH activity. To test this possibility, in the present study, we have investigated anandamide internalization in wild-type and FAAH-deficient (FAAH –/– ) mice. Cortical neurons from either mouse strain internalized [ 3 H]anandamide through a similar mechanism, i.e., via a rapid temperature-sensitive and saturable process, which was blocked by AM404. Moreover, systemic administration of AM404 to either wild-type or FAAH –/– mice enhanced the hypothermic effects of exogenous anandamide, a response that was prevented by the CB 1 cannabinoid antagonist rimonabant (SR141716A). The results indicate that anandamide internalization in mouse brain neurons is independent of FAAH activity. In further support of this conclusion, the compound N -(5Z, 8Z, 11Z, 14Z eicosatetraenyl)-4-hydroxybenzamide (AM1172) blocked [ 3 H]anandamide internalization in rodent cortical neurons and human astrocytoma cells without acting as a FAAH substrate or inhibitor. AM1172 may serve as a prototype for novel anandamide transport inhibitors with increased metabolic stability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Self-citationRole of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Self-citationCravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Self-citationFunctional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Self-citationBrewer, G. J. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420510 · Cited by 541
Research works printed but not linked: 2
- Masson, J., Sagne, C., Hamon, M. & El Mestikawy, S. (1999) Pharmacol. Rev. 51, 439–464.10471414
- Ligresti A. Morera E. Van Der Stelt M. M. Monory K. Lutz B. Ortar G. & Di Marzo V. (2004) Biochem. J. in press.
Cited by
Items 101–200 of 239
Yates, M. L., & Barker, E. L. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055251 · Cited by 62
“…(Hillard and Jarrahian, 2000) indicate that the elusive membrane-localized AEA carrier is capable of the trans-flux coupling effect, a phenomenon whereby in response to extracellular AEA, the membrane-localized carrier protein accumulates at the cell surface in the extracellular-facing direction.”
BackgroundThe Endocannabinoid System: Current Pharmacological Research and Therapeutic Possibilities
Jonsson, K., Holt, S., & Fowler, C. J. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_376.x · Cited by 57
Mode of action of cannabinoids on nociceptive nerve endings
Kress, M., & Kuner, R. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1762-0 · Cited by 56
Chesterfield, A. K., Kidd, S. R., Moore, S. A., Schaus, J. M., Liu, B., Nomikos, G. G., & Felder, C. C. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9072-6 · Cited by 55
“AM1172 was originally claimed to be a specific potent and selective inhibitor of anandamide uptake (IC50 = 2–2.6 µM), with no effect on FAAH activity and resistance to hydrolysis by FAAH, unlike AM404 or VDM11 (Fegley et al., 2004).”
BackgroundInfluentialCannabinoids Biology: The Search for New Therapeutic Targets
Felder, C. C., Dickason-Chesterfield, A. K., & Moore, S. A. (2006) · Molecular Interventions · doi:10.1124/mi.6.3.6 · Cited by 55
BDNF‐induced endocannabinoid release modulates neocortical glutamatergic neurotransmission
Yeh, M. L., Selvam, R., & Levine, E. S. (2017) · Synapse · doi:10.1002/syn.21962 · Cited by 47
“Next, we employed the eCB transport inhibitor, AM404 (Beltramo et al., 1997; Di Marzo et al., 1994; Fegley et al., 2004; Hillard, Edgemond, Jarrahian, & Campbell, 1997) in the patch pipette to provide further evidence for postsynaptic BDNF-induced eCB release at layer 5 excitatory synapses.”
MethodInfluentialEffects of endocannabinoid neurotransmission modulators on brain stimulation reward
Vlachou, S., Nomikos, G. G., & Panagis, G. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0506-0 · Cited by 50
“…hydrolysis of anandamide (Deutsch and Chin 1993; Hillard et al. 1995); URB-597, an inhibitor of intracellular FAAH activity (Kathuria et al. 2003; Fegley et al. 2004, 2005) and OMDM-2, a selective and metabolically stable inhibitor of anandamide cellular uptake that has minimal activity against…”
BackgroundVandevoorde, S., & Fowler, C. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706253 · Cited by 51
Zaniewska, M., McCreary, A. C., Przegaliński, E., & Filip, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.034 · Cited by 48
Accumulation of anandamide: Evidence for cellular diversity
Hillard, C. J., & Jarrahian, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.012 · Cited by 47
“For example, FAAH-null cells (Day et al., 2001; Glaser et al., 2003; Fegley et al., 2004) and synaptosomes prepared from FAAH-null mice (Ligresti et al., 2004) exhibit robust and saturable accumulation of AEA.”
BackgroundSeillier, A., Aguilar, D. D., & Giuffrida, A. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.05.022 · Cited by 46
“While the existence of an active reuptake remains controversial (Fegley et al., 2004; Fu et al., 2012; McFarland et al., 2004), the catabolic enzymes responsible for AEA and 2-AG 74”
Miller, L. L., Picker, M. J., Umberger, M. D., Schmidt, K. T., & Dykstra, L. A. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191478 · Cited by 44
Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models
Mitchell, V. A., Greenwood, R., Jayamanne, A., & Vaughan, C. W. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04692.x · Cited by 43
“levels in plasma and brain with a time-course similar to the antiallodynia observed in the present study.(35,37) Although AM404 also inhibits FAAH,(17,35,36,38) the effects of AM404 observed in the present study were unlikely to be due to FAAH inhibition.”
ResultAnandamide-induced behavioral disruption through a vanilloid-dependent mechanism in rats
Panlilio, L. V., Mazzola, C., Medalie, J., Hahn, B., Justinová, Z., Drago, F., Cadet, J. L., Yaşar, S., & Goldberg, S. R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1399-x · Cited by 43
“We also studied the effects of combining anandamide with URB597, a drug that inhibits fatty acid amide hydrolase (FAAH), the enzyme primarily responsible for metabolizing anandamide (Fegley et al. 2004).”
Endocannabinoids: Getting the message across
Alger, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402935101 · Cited by 43
Endocannabinoid signaling in neurotoxicity and neuroprotection
Pope, C., Mechoulam, R., & Parsons, L. H. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.002 · Cited by 47
Membrane transport of anandamide through resealed human red blood cell membranes
Bojesen, I. N., & Hansen, H. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400498-jlr200 · Cited by 41
Bernardes, G. J. L., Linderoth, L., Doores, K. J., Boutureira, O., & Davis, B. G. (2011) · ChemBioChem · doi:10.1002/cbic.201100125 · Cited by 40
Giuffrida, A., & McMahon, L. R. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.05.004 · Cited by 41
Ligresti, A., PETROCELLIS, L. D., de la Ossa, D. H. P., Aberturas, M. R., Cristino, L., Moriello, A. S., Fińizio, A., Gil-Alegre, M. E., Torres‐Suárez, A. I., Molpeceres, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010239 · Cited by 42
“The effect of AEA (1 mM), apart from the selective inhibitor of TRPV1 channels, 59-iodo-resiniferatoxin (I-RTX), was significantly reduced by: 1) bovine serum albumin (BSA), which sequesters AEA from the extracellular medium; 2) OMDM-1 (a specific inhibitor of AEA cellular uptake with no effect on AEA enzymatic hydrol…”
BackgroundInfluentialRuggieri, V., Vitale, G., Pini, L. A., & Sandrini, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0284-9 · Cited by 44
An Overview on the Biochemistry of the Cannabinoid System
Gómez‐Ruíz, M., Hernández, M., de Miguel, R., & Ramos, J. A. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0015-0 · Cited by 47
“To date, it is generally accepted that the movement of anandamide through the cell membrane is a saturable process, and different mechanisms for the uptake of anandamide have been proposed, which include: (1) facilitated diffusion mediated by a membrane carrier [112, 113], (2) simple diffusion driven by FAAH-mediated…”
BackgroundThe endogenous cannabinoid system and the treatment of marijuana dependence
Piomelli, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.018 · Cited by 40
“AM404 increases endogenous anandamide levels in brain tissue and peripheral blood of rats and mice (Fegley et al., 2004; Giuffrida et al., 2000).”
BackgroundResultSelf-citationScheyer, A. F., Yasmin, F., Naskar, S., & Patel, S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01438-7 · Cited by 40
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids
Liedhegner, E. S., Vogt, C. D., Sem, D. S., Cunningham, C. W., & Hillard, C. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8651-7 · Cited by 39
Hillard, C. J., Shi, L., Tuniki, V. R., Falck, J. R., & Campbell, W. B. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0045-0 · Cited by 37
“1997b); N(5Z, 8Z, 11Z, 14Z eicosatetraenyl)-4-hydroxybenzamide (AM1172), (Fegley et al. 2004); N-arachidonyl-2-methyl, 4-hydroxyphenylamine (VDM11); N-arachidonyl-3-furylmethylamine (UCM707) (Lopez-Rodriguez et al.”
InfluentialRole of TRPV1 and cannabinoid CB1 receptors in AM 404-evoked hypothermia in rats
RAWLS, S., DING, Z., & COWAN, A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.011 · Cited by 35
New tetrazole-based selective anandamide uptake inhibitors
Ortar, G., Moriello, A. S., Cascio, M. G., PETROCELLIS, L. D., Ligresti, A., Morera, E., Nalli, M., & Marzo, V. D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.04.003 · Cited by 36
Price, T. J., Patwardhan, A. M., Flores, C. M., & Hargreaves, K. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.031 · Cited by 36
“However, the persistence of AEA accumulation in FAAH knockout mice indicates that another mechanism, different from FAAH, and pharmacologically blocked by AMT inhibitors, plays an essential role in this process (Fegley et al., 2004;Ortega-Gutierrez et al., 2004).”
BackgroundZogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 41
“Thus, endocannabinoid signalling functions are efficiently terminated by cellular uptake and rapid, enzyme-catalyzed hydrolytic inactivation (Di Marzo, 2008; Fegley et al., 2004).”
BackgroundCamu, F., Borgeat, A., Heylen, R. J., Viel, E., Boye, M. E., & Cheung, R. Y. (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12841 · Cited by 34
Glaser, S. T., Deutsch, D. G., Studholme, K. M., ZIMOV, S., & Yazulla, S. (2005) · Visual Neuroscience · doi:10.1017/s0952523805226020 · Cited by 38
“There are several reports that have identified analogues of AEA that inhibited cellular uptake of AEA with no inhibition of FAAH ~López-Rodríguez et al., 2003; Ortar et al., 2003, Fegley et al., 2004a,b!.”
BackgroundHillard, C. J., Ho, W. ‐. V., Thompson, J., Gauthier, K. M., Wheelock, C. E., Huang, H., & Hammock, B. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707468 · Cited by 34
“Two inhibitors of cellular accumulation of anandamide, AM1172 (Fegley et al., 2004) and VDM11 (De Petrocellis et al.”
BackgroundInfluentialMetabolism of AM404 From Acetaminophen at Human Therapeutic Dosages in the Rat Brain
Muramatsu, S., Shiraishi, S., Miyano, K., Sudo, Y., Toda, A., Mogi, M., Hara, M., Yokoyama, A., Kawasaki, Y., Taniguchi, M., et al. (2016) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.32873 · Cited by 32
“AM404 acts as a potent activator of transient receptor potential cation channel subfamily V member 1 (TRPV1), as a ligand at cannabinoid CB1 receptors (4), or as an inhibitor of anandamide uptake, which is an endogenous agonist for both TRPV1 and CB1 receptors, subsequently increasing the concentrations of endogenous…”
BackgroundNicolussi, S., Chicca, A., Rau, M., Rihs, S., Soeberdt, M., Abels, C., & Gertsch, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.09.020 · Cited by 38
Cannabinoids, Electrophysiology, and Retrograde Messengers: Challenges for the Next 5 Years
Straiker, A. J., & Mackie, K. (2006) · The AAPS Journal · doi:10.1007/bf02854897 · Cited by 39
Sandberg, A., & Fowler, C. J. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2004.12.010 · Cited by 30
Thors, L., Alajakku, K., & Fowler, C. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707172 · Cited by 31
“UCM707 can inhibit AEA uptake in either cells lacking FAAH, preparations from FAAH / mice or in cells pretreated with FAAH inhibitors (Day et al., 2001; Fegley et al., 2004; Ortega-Gutiérrez et al., 2004; but see Kaczocha et al., 2006), and so it is possible that these compounds may be blocking”
BackgroundResultInfluentialModulators of Endocannabinoid Enzymic Hydrolysis and Membrane Transport
Ho, W. ‐. V., & Hillard, C. J. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_6 · Cited by 33
Goonawardena, A. V., Sesay, J., Sexton, C. A., Riedel, G., & Hampson, R. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.003 · Cited by 31
“This is despite doses used that have previously been confirmed to potently elevate anandamide levels in vivo (Fegley et al., 2004; Pamplona et al., 2008; Abush and Akirav, 2010; Glaser et al., 2005; Fowler et al., 2004) and may be interpreted in two ways: 1) URB597 is more potent than AM404 or 2) their differential ph…”
InfluentialPlaczek, E. A., Okamoto, Y., Ueda, N., & Barker, E. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.047 · Cited by 30
“…in FAAH knockout mice have confirmed that AEA uptake appears to be modulated by both FAAH-dependent and FAAH-independent mechanisms (Ortega-Gutiérrez et al., 2004) as temperature-sensitive AEA uptake occurs in preparations from FAAH knockout mice (Fegley et al., 2004; Ligresti et al., 2004).”
BackgroundLynch, D. L., & Reggio, P. H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058185d · Cited by 29
Behavioral Neurobiology of the Endocannabinoid System
Kendall, D., & Alexander, S. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7 · Cited by 29
de Lago, E., Gustafsson, S. B., Fernández‐Ruíz, J., Nilsson, J. A., Jacobsson, S. O. P., & Fowler, C. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04104.x · Cited by 29
“The IC50 value for this compound as an inhibitor of uptake varies considerably between studies, values of 0.8 lM (U937 human lymphoma cells), 4 and 3 lM (neuronal cell cultures from embryonic FAAH+/+ and FAAH–/– mice, respectively), 25 lM (rat RBL2H3 basophilic leukaemia cells) and 40 lM (rat C6 glioma cells) having b…”
InfluentialAutism and associated disorders: cannabis as a potential therapy
Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 35
Chapter 2 Organized Trafficking of Anandamide and Related Lipids
Yates, M. L., & Barker, E. L. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81002-9 · Cited by 31
“AEA uptake is driven by, but not necessarily dependent upon, FAAH activity (Day et al., 2001; Deutsch et al., 2001; Fegley et al., 2004; Hillard et al., 2007; Ligresti et al., 2004).”
BackgroundInfluentialIncreased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain
Khasabova, I. A., Holman, M. A., Morse, T., Burlakova, N., Coicou, L. G., Harding-Rose, C., Simone, D. A., & Seybold, V. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.018 · Cited by 26
Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation
Iring, A., Ruisanchez, É., Leszl-Ishiguro, M., Horváth, B., Benkő, R., Lacza, Z., Járai, Z., Sándor, P., Marzo, V. D., Pacher, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053390 · Cited by 27
“cannabinoid reuptake inhibitor AM-404 in a dose of 10 mg kg(21), which had been shown in previous studies to result in a more than 3-fold increase in the endogenous levels of anandamide in the mouse brain [38].”
Caballero, F. J., Navarrete, C. M., Hess, S., Fiebich, B. L., Appendino, G., Macho, A., Muñóz, E., & Sancho, R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.001 · Cited by 30
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation
Fezza, F., Oddi, S., Tommaso, M. D., Simone, C. D., Rapino, C., Pasquariello, N., Dainese, E., Finazzi‐Agrò, A., & Maccarrone, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700486-jlr200 · Cited by 30
Caballero, F. J., Soler-Torronteras, R., Lara‐Chica, M., García, V., Fiebich, B. L., Muñóz, E., & Calzado, M. A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.023 · Cited by 27
AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain
Borsani, E., Labanca, M., Bianchi, R., & Rodella, L. F. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.071 · Cited by 27
New insights on endocannabinoid transmission in psychomotor disorders
Giuffrida, A., & Seillier, A. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.002 · Cited by 27
“The biological actions of AEA are terminated via a carrier-mediated uptake, whose molecular identity remains controversial (Fegley et al., 2004; Glaser et al., 2003; Hillard and Jarrahian, 2003), followed by enzymatic hydrolysis via a fatty acid amide hydrolase (FAAH) (Cravatt et al., 1996; Wei et…”
Development of the First Potential Covalent Inhibitors of Anandamide Cellular Uptake
Moriello, A. S., Balas, L., Ligresti, A., Cascio, M. G., Durand, T., Morera, E., Ortar, G., & Marzo, V. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051226l · Cited by 24
The anandamide membrane transporter and the therapeutic implications of its inhibition
Battista, N., Gasperi, V., Fezza, F., & Maccarrone, M. (2005) · Therapy · doi:10.1586/14750708.2.1.141 · Cited by 25
“Therefore excluding the involvement of TRPV1, the avoidance of CT-induced fluid accumulation by administration of VDM11 has suggested that 148 Therapy (2005) 2(1) drugs inhibiting AMT could have an antisecretory role in the small intestine [73].”
BackgroundResultInfluentialDoes the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
Fowler, C. J., & Ghafouri, N. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.07.002 · Cited by 23
“[4] Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, et al.”
BackgroundThe Pharmacology of the Cannabinoid System—A Question of Efficacy and Selectivity
Fowler, C. J. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0001-6 · Cited by 25
“Because FAAH has a wide substrate selectivity, inhibition of FAAH in vivo leads to increases in the concentration not only of AEA but also of other N-acylethanolamine substrates, such as palmitoylethanolamide and oleoylethanolamide, as well as other lipids such as the N-acyl taurines [94, 96, 103], which have a range…”
BackgroundEndocannabinoid Liberation from Neurons in Transsynaptic Signaling
Lovinger, D. M. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0043-2 · Cited by 25
“However, newly developed uptake blockers do not inhibit FAAH with appreciable potency (Fegley et al. 2004; Moore et al. 2005), and 2-AG, which appears to be taken up via the AMT, does not appear to act as a FAAH substrate in vivo and in certain subtypes of cultured cells that show apparent AMT activity (Beltramo and P…”
BackgroundInfluentialSmita, K., Kumar, V., & Premendran, J. S. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00454.x · Cited by 27
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys
Schindler, C. W., Scherma, M., Redhi, G. H., Vadivel, S. K., Makriyannis, A., Goldberg, S. R., & Justinová, Z. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4211-3 · Cited by 22
“The most studied anandamide transport inhibitor, AM404 (N-(4-hydroxyphenyl)-arachidonamide), has been shown to increase the endogenous brain levels of anandamide in both mice and rats (Bortolato et al. 2006; Fegley et al. 2004), as well as the levels of anandamide in rat plasma (Beltramo et al.”
BackgroundSelf-citationBjörklund, E., Blomqvist, A., Hedlin, J., Persson, E., & Fowler, C. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103479 · Cited by 22
Ayoub, S. S., Pryce, G., Seed, M. P., Bolton, C., Flower, R. J., & Baker, D. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038638 · Cited by 20
“The dose of anandamide used in the present study is within the pharmacological range (Fegley et al., 2004).”
Reynoso-Moreno, I., Chicca, A., Flores-Soto, M. E., Paredes, J. M. V., & Gertsch, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00180 · Cited by 21
“However, in an in vitro model of neuroinflammation, the pharmacological effects of the MAGL inhibitor JZL184 and the FAAH inhibitor URB597 were shown to be mediated by PPARγ in a CB1 receptor-depended manner (Du et al., 2011).”
BackgroundInfluentialPitfalls and solutions in assaying anandamide transport in cells
Oddi, S., Fezza, F., Catanzaro, G., Simone, C. D., Pucci, M., Piomelli, D., Finazzi‐Agrò, A., & Maccarrone, M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.d004176 · Cited by 20
Self-citationEffect of an unstirred layer on the membrane permeability of anandamide
Bojesen, I. N., & Hansen, H. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500411-jlr200 · Cited by 20
“The transport mechanism of anandamide has lately been much discussed, and evidence has been presented of a facilitated as well as of a simple diffusion (9, 11, 13, 17, 21, 22).”
BackgroundEndocannabinoid Signaling in the Striatum
Lovinger, D. M., Davis, M. I., & Costa, R. M. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00009-3 · Cited by 18
CB1 receptor-mediated respiratory depression by endocannabinoids
Iring, A., Hricisák, L., & Benyó, Z. (2017) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2017.02.011 · Cited by 12
Bunsick, D. A., Matsukubo, J., Aldbai, R., Baghaie, L., & Szewczuk, M. R. (2024) · Cells · doi:10.3390/cells13060480 · Cited by 11
“AM-404 is an indirect agonist of the CB1 receptor by binding to the fatty acid amide hydrolase (FAAH) enzyme, preventing anandamide breakdown [36,37].”
BackgroundEndocannabinoid modulation of jejunal afferent responses to LPS
Donovan, J., & Grundy, D. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01961.x · Cited by 11
Tutka, P., Właź, A., Florek-Łuszczki, M., Kołodziejczyk, P., Bartusik‐Aebisher, D., & Łuszczki, J. J. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.08.006 · Cited by 11
“AM 1172 blocked [3H] anandamide internalization in rodent cortical neurons and human astrocytoma cells [14].”
BackgroundScienza-Martin, K., Lotz, F. N., Zanona, Q. K., Santana, F., Crestani, A. P., Boos, F. Z., Calcagnotto, M. E., & Quillfeldt, J. A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.04.009 · Cited by 12
Effect of olvanil and anandamide on vagal C‐fiber subtypes in guinea pig lung
Lee, M., Weinreich, D. M., & Undem, B. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706339 · Cited by 11
“…demonstrated that diffusion of fatty-acid amide agonists such as AEA and olvanil can be substantially facilitated by an as of yet unidentified molecular mechanism (Di Marzo et al., 1998; Beltramo & Piomelli, 1999; De Petrocellis et al., 2000; 2001; Hillard & Jarrahian, 2003; Fegley et al., 2004).”
BackgroundOleson, E. B., & Cheer, J. F. (2012) · Synapse · doi:10.1002/syn.21587 · Cited by 11
“…studies report that VDM11 is also a substrate for FAAH, capable of reducing the metabolism of FAAH hydrolysis products (e.g., anandamide, palmitoylethanolamide, and oleoylethanolamide) (Hillard et al., 2007; Vandevoorde and Fowler, 2005) but see Bortolato et al. (2006) and Fegley et al. (2004).”
BackgroundHasanein, P., & Javanmardi, K. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00626.x · Cited by 10
Hansen, H. S., Petersen, G. L., Artmann, A., & Madsen, A. N. (2006) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200600157 · Cited by 11
The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis
Hasanein, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.026 · Cited by 10
Endocannabinoid Receptor Genetics and Marijuana Use
Gong, J., Leonard, C. M., Akinshola, B. E., Onaivi, E. S., Lin, Z., Uhl, G. R., Ishiguro, H., Zhang, P. W., & Chirwa, S. (2005) · CRC Press eBooks · doi:10.1201/9781420023640.pt2 · Cited by 8
Pharmacological and toxicological effects of paracetamol: current knowledge and a review
Athbhaiya, G., Tiwari, A., Choudhary, R., & Samal, P. K. (2026) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2604674 · Cited by 9
“…shown to possess analgesic properties by inhibiting endocannabinoid reuptake, thereby preventing the reuptake of anandamide from the synaptic cleft (Fegley et al., 2004). it is interesting to mention the role of cOx-2 in the oxygenation and thus metabolism of the endocannabinoids. in the case of…”
Mechanism of Action, Kinetics and a Bioactive Metabolites AM404 of Paracetamol
Singh, S., & Kaur, M. (2020) · Journal of Clinical Medical Research · doi:10.46889/jcmr.2020.1201 · Cited by 7
“AM404 may be a potent agonist of the TRPV1 receptor that is transient receptor potential vanilloid kind one, associate degree Anandamide Membrane Transporter (AMT) blocker, a low-affinity substance of the sort one Cannabinoid receptor (CB1) and what is more, it has been shown that AM404 induces physiological condition…”
BackgroundMarzęda, P., Wróblewska-Łuczka, P., Florek-Łuszczki, M., Góralczyk, A., & Łuszczki, J. J. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00557-2 · Cited by 7
“…combined with CDDP produced only additive interactions, which may be a result of different mechanisms of action, i.e., raising AEA levels by AM1172 [34–36], and CDDP-induced DNA lesions via interaction with purine bases on DNA, leading finally to cell apoptosis or necrosis by the two-drug mixture…”
Background6 Recent Progress in Cannabinoid Research
Adam, J., Cowley, P. M., Kiyoi, T., Morrison, A. J., & Mort, C. (2006) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(05)44406-9 · Cited by 8
Endocannabinoid Metabolism and Transport as Drug Targets
Ciaramellano, F., Fanti, F., Scipioni, L., Maccarrone, M., & Oddi, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_16 · Cited by 6
Endocannabinoids and Their Synthetic Analogs
Vemuri, K. V., & Makriyannis, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-503-9_2 · Cited by 8
“cophoric features necessary for transport inhibition while maintaining metabolic stability against enzymatic hydrolysis [162].”
BackgroundSelf-citationBialecki, J., Weilinger, N. L., Lohman, A. W., Vecchiarelli, H. A., Robinson, J. H. B., Huguet, J. E., Medizabal-Zubiaga, J., Werner, A. C., Grandes, P., Teskey, G. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/263640 · Cited by 6
Inhibition of Adult Neurogenesis in Male Mice after Repeated Exposure to Paracetamol Overdose
Suárez, J., de Ceglia, M., Rodríguez-Pozo, M., Vargas, A., Santos, I., Melgar‐Locatelli, S., Castro‐Zavala, A., Castilla‐Ortega, E., de Fonseca, F. R., Decara, J. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25041964 · Cited by 5
“Recent evidence shows that APAP efficacy may depend on its transformation into N-arachidonoylphenolamine (AM404), an active metabolite that activates transient receptor potential vanilloid-1 (TRPV1) and inhibits endocannabinoid anandamide (AEA) reuptake from the synaptic cleft [13].”
BackgroundBunsick, D. A., Baghaie, L., Li, Y., Yaish, A. M., Aucoin, E. B., Skapinker, E., Aldbai, R., & Szewczuk, M. R. (2025) · Cells · doi:10.3390/cells14020071 · Cited by 5
“AM-404 is an indirect agonist of the CB1 receptor by binding to the fatty acid amide hydrolase (FAAH) enzyme, preventing anandamide breakdown [30,31].”
Załuska-Ogryzek, K., Wróblewska-Łuczka, P., Góralczyk, A., & Łuszczki, J. J. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111392 · Cited by 5
Tsuchiya, H., & Mizogami, M. (2025) · Future Pharmacology · doi:10.3390/futurepharmacol5030040 · Cited by 9
“After a 30 min incubation, however, AM404 of 0.1–1 nmol was rapidly degraded by brain membranes from wild-type mice, but not by those from FAAH knockout mice [61].”
InfluentialInteractions of Cannabis and Amphetamine-Type Stimulants
Tambaro, S., & Bortolato, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_16 · Cited by 7
“Following release and activation of CB receptors, anandamide is rapidly removed from the synaptic cleft by a carriermediated system [131–134] and subsequently hydrolyzed by the membrane enzyme fatty acid amide hydrolase (FAAH) [135–137].”
MethodEndocannabinoid Signaling in the Striatum
Lovinger, D. M., & Mathur, B. N. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00010-6 · Cited by 6
Pharmacological Tools in Endocannabinoid Neurobiology
Mor, M., & Lodola, A. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_4 · Cited by 5
“Modulation of the activity of ECBs revealed therapeutic promises in a wide range of diseases and pathological conditions ( Elsohly 2002 ), possibly overcoming the traditional limit to the development of cannabinoid-based medicines, i. e. the socially intolerable psychoactive properties of plant-derived or synthetic ag…”
BackgroundDelgado, A., & Jaffe, E. H. (2011) · International Journal of Cell Biology · doi:10.1155/2011/529851 · Cited by 4
“Apparently, they may also be associated with an old and widely used drug as acetaminophen/paracetamol, which is metabolized to a bioactive cannabimimetic drug AM404, an inhibitor of endocanabinoid uptake [6, 7].”
BackgroundInfluentialRegulation of Synaptic Function by Endocannabinoids
Lovinger, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370509-9.00028-0 · Cited by 5
Endocannabinoid biochemistry: What do we know after 50 years?
Fezza, F., & Maccarrone, M. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch3 · Cited by 5
López-Jaramillo, P. A., Pradilla, L. P., Bracho, Y., & Silva, F. (2005) · Revista Colombiana de Cardiología · Cited by 3
Endocannabinoid-Dependent Synaptic Plasticity in the Striatum
Atwood, B. K., & Lovinger, D. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_5 · Cited by 3
Harry, G. J. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.06.001 · Cited by 2
Búsqueda de un tratamiento farmacológico para la dependencia de la marihuana
Atance, J. A. R. (2006) · Adicciones · doi:10.20882/adicciones.351 · Cited by 6
The Pannexin-1 N-terminal Helix Gates a Switch between Ion Conductance and Anandamide TransportPreprint
Anderson, C. L., Weilinger, N. L., Visser, F., Nielsen, A. C., Boyce, A. K. J., & Thompson, R. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.11.584466 · Cited by 2
“In most cases of the proposed transport mechanisms, AEA metabolism by FAAH or binding to intracellular fa\y acid binding proteins helps to maintain an intracellular ‘sink’ for a sustained inward driving force 11–14 .”
BackgroundThe day anandamide almost died, and other endocannabinoid stories
Piomelli, D. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00004-9 · Cited by 1
Self-citation
Metadata
- Authors
- Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D.
- Affiliations
- University of Connecticut (US)
- Corresponding author
- Piomelli, D.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-05-11
- Volume
- 101
- Issue
- 23
- Pages
- 8756-8761
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC423268
- OpenAlex
- W2087723063
- Cited by
- 230
- References
- 36
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 8 · 2016: 5 · 2015: 5 · 2014: 13 · 2013: 9 · 2012: 10
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (DA3801, DA-3412, R01DA003801, K05DA000493, R01DA012447, DA09185, Z01DA000493, DA12447, R37DA003801)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- anandamide, fatty acid amide hydrolase, AM404, passive diffusion, endocannabinoid system, CB1 receptor, rimonabant, hypothermic effect, cortical neurons, astrocytes
- MeSH terms
- Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonic Acids, Benzamides, Biological Transport, Active, Cell Line, Humans, Hydrolysis, Mice, Inbred C57BL, Neurons, Rats, Wistar, Mice, Knockout, Mice, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.